Pre-market Hot Trades in US Stocks
Coreweave is down 3.34% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 22, Citigroup updated its rating on CoreWeave to &#34;Buy,&#34; but lowered the target price to $135, warning of limited trading history and customer concentration risk. This led to stock price volatility. Source: Barron’s
</li>
<li>
On December 20, CoreWeave secured $2.5 billion in financing, driven by strong market demand for AI infrastructure, pushing the stock price up. Source: Benzinga
</li>
<li>
On December 19, CoreWeave's stock price surged 22.64% due to a recoverage by an investment firm, closing at $83. Source: MoneyDJAI Strong market demand and significant capital inflow.
</li>
</ol>
Nebius is down 3.13% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 22, analysts believe that Nebius's exit from the Russian market reduces risk and supports global growth plans. Analysts gave Nebius a strong buy rating with a target price of $164.20, representing about 84% upside from current levels. Source: TipRanks
</li>
<li>
On December 19, as Micron's financial forecast exceeded expectations, strong market expectations for AI demand drove a rebound in Nebius's stock price. Analysts noted that market concerns about debt may be overstated, with Nebius's stock rising 8.5%. Source: MarketWatch
</li>
<li>
On December 20, Nebius's annualized return over the past decade was 18.71%, outperforming the market. The current market capitalization is $22.33 billion, with significant long-term investment returns. Source: Benzinga Strong AI demand and reduced market concerns about debt.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Trinity Biotechnology-A is up 83.86% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 23, Trinity Biotechnology received an order for 9 million TrinScreen HIV tests. This order is expected to significantly boost the company's revenue and profitability, driving the stock price up. Source: Reuters
</li>
<li>
On December 23, the company's third-quarter revenue grew 32% compared to the second quarter, reaching $14.3 million. This financial performance enhanced market confidence, further driving the stock price up. Source: Reuters
</li>
<li>
On December 23, the company announced that its manufacturing process received approval from the World Health Organization, improving production efficiency and cost-effectiveness. This move helps meet order demand and improves profit prospects. Source: Reuters Strong demand in the biotechnology sector and increased market volatility.
</li>
</ol>
Haiwei Metal Processing is up 75.90% in pre-market trading, with no significant recent news. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation
Vivakor pre-market rose 34.31%. Based on recent key news:
<ol>
<li>
On December 22, Vivakor announced the signing of a letter of intent to acquire Coyote Oilfield Services, expanding its midstream and oilfield service capabilities. This move will enhance expertise in pipeline development, terminal operations, oilfield services, and energy marketing. This news drove Vivakor's stock price up 34.31% in pre-market trading. Source: Company press release
</li>
<li>
On December 22, the acquisition agreement between Vivakor and Coyote is expected to be completed by February 28, 2026, subject to customary conditions. This news further boosts market confidence in Vivakor's future development. Source: Reuters
</li>
<li>
On December 22, Vivakor emphasized the strategic significance of the acquisition in a press release published through GlobeNewswire, further driving the stock price up. Source: GlobeNewswire The oilfield services industry has performed strongly recently, attracting market attention
</li>
</ol>

CRWV

NBIS

Coreweave pre-market down 3.34%; Nebius pre-market down 3.13%; Trinity Biotech-A pre-market up 83.86%; Haive Metal Processing pre-market up 75.90%; Vivakor pre-market up 34.31%

Pre-market hot trades in US stocks: Coreweave pre-market down 3.34%; Nebius pre-market down 3.13%